Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition. (Q38996793)
Jump to navigation
Jump to search
scientific article published on 8 May 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition. |
scientific article published on 8 May 2014 |
Statements
Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition (English)
Stefania Napolitano
Donata Vitagliano
Anna Nappi
Davide Ciardiello
Erika Martinelli
Fortunato Ciardiello